Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up
- PMID: 8175032
Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up
Abstract
Background and methods: Infections represent the major cause of death in chronic lymphocytic leukemia (CLL); however, clinical studies dealing with their incidence have yielded inconclusive results. In order to address this issue we reviewed the records of 125 CLL patients (mean age 65.6 yrs; 81 M/44 F; Stage A, 48; Stage B, 37; Stage C, 40) followed up at our institution over a 10-year period.
Results: The 125 patients accrued 447 person-years, a mean of 3.8 years per person. There were 199 recorded infections: 47 severe (crude rate 9.8 per 100 person-years) and 72 moderate, respectively. The 5-year risk of developing a severe infection for the whole series was 26% (95% CI: 24.7-27.3%), and 21 out of 71 deaths (29.5%) could be attributed to infectious causes. Despite a linear trend toward increased risk (r = 0.98), hazard function analysis showed a constant pattern of risk (r = 0.30), suggesting a lack of correlation of this event with time. Furthermore, the 5-year risk of developing a severe infection increased to 57.1% (95% CI: 36.4-77.8%) for patients with low IgG levels (less than 6.5 gr/L), and to 68% for those with both low IgG levels and disease stage C. On the other hand, patients who experienced a severe infection more frequently had advanced clinical stage (P < 0.001), low IgG levels (P < 0.01) and diffuse bone marrow (BM) histology (P < 0.05).
Conclusions: Infection is a constant risk in CLL that is associated with shortened survival. Factors such as hypogammaglobulinemia and advanced disease appear to be the major predisposing factors.
Similar articles
-
Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.Haematologica. 1997 May-Jun;82(3):286-90. Haematologica. 1997. PMID: 9234573
-
Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.Haematologica. 1999 Dec;84(12):1094-9. Haematologica. 1999. PMID: 10586211 Clinical Trial.
-
[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].Acta Med Croatica. 2008 Oct;62(4):351-64. Acta Med Croatica. 2008. PMID: 19205412 Croatian.
-
Second neoplasms in chronic lymphocytic leukemia: analysis of incidence as a function of the length of follow-up.Haematologica. 1989 Sep-Oct;74(5):481-5. Haematologica. 1989. PMID: 2511118
-
Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment.Leuk Lymphoma. 1994 Apr;13(3-4):203-14. doi: 10.3109/10428199409056283. Leuk Lymphoma. 1994. PMID: 8049645 Review.
Cited by
-
Immunologic monitoring in chronic lymphocytic leukemia.Curr Oncol Rep. 2003 Sep;5(5):419-25. doi: 10.1007/s11912-003-0029-3. Curr Oncol Rep. 2003. PMID: 12895395 Review.
-
Infections in patients with chronic lymphocytic leukemia.Hematol Transfus Cell Ther. 2023 Jul-Sep;45(3):387-393. doi: 10.1016/j.htct.2023.05.006. Epub 2023 Jul 1. Hematol Transfus Cell Ther. 2023. PMID: 37407362 Free PMC article. Review.
-
Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia.Eur J Clin Invest. 2009 Jun;39(6):497-506. doi: 10.1111/j.1365-2362.2009.02131.x. Eur J Clin Invest. 2009. PMID: 19490058 Free PMC article.
-
Outcomes in critically ill chronic lymphocytic leukemia patients.Support Care Cancer. 2013 Jul;21(7):1885-91. doi: 10.1007/s00520-013-1744-4. Epub 2013 Feb 15. Support Care Cancer. 2013. PMID: 23411999
-
The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells.Leukemia. 2016 Jan;30(1):163-72. doi: 10.1038/leu.2015.174. Epub 2015 Jul 3. Leukemia. 2016. PMID: 26139429 Free PMC article.